These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1562118)
21. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. Best JF; Rinkenberger R; Lynch L; Dunn M Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656 [TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia. Saksena S; Rothbart ST; Shah Y; Cappello G Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016 [TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of amiodarone. The low-dose perspective. Kowey PR; Friehling TD; Marinchak RA; Sulpizi AM; Stohler JL Chest; 1988 Jan; 93(1):54-9. PubMed ID: 3335168 [TBL] [Abstract][Full Text] [Related]
24. Chronic effects of amiodarone in patients with refractory ventricular tachycardia. Saksena S; Rothbart ST; Cappello G Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. Graboys TB; Podrid PJ; Lown B Am Heart J; 1983 Oct; 106(4 Pt 2):870-6. PubMed ID: 6613832 [TBL] [Abstract][Full Text] [Related]
27. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients. Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368 [TBL] [Abstract][Full Text] [Related]
28. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness. Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112 [TBL] [Abstract][Full Text] [Related]
29. Amiodarone in the management of refractory atrial fibrillation. Blevins RD; Kerin NZ; Benaderet D; Frumin H; Faitel K; Jarandilla R; Rubenfire M Arch Intern Med; 1987 Aug; 147(8):1401-4. PubMed ID: 3307669 [TBL] [Abstract][Full Text] [Related]
30. Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone. De Paola AA; Horowitz LN; Spielman SR; Brady P; Morganroth J; Greenspan AM; Kay HR Am J Cardiol; 1987 Aug; 60(4):276-80. PubMed ID: 3303888 [TBL] [Abstract][Full Text] [Related]
32. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. Ochi RP; Goldenberg IF; Almquist A; Pritzker M; Milstein S; Pedersen W; Gobel FL; Benditt DG Am J Cardiol; 1989 Sep; 64(10):599-603. PubMed ID: 2782249 [TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of amiodarone as an antiarrhythmic agent. Rosenbaum MB; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ; Lázzari JO; Elizari MV Am J Cardiol; 1976 Dec; 38(7):934-44. PubMed ID: 793369 [TBL] [Abstract][Full Text] [Related]
34. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429 [TBL] [Abstract][Full Text] [Related]
35. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias. Hermida JS; Tcheng E; Jarry G; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C Europace; 2004 Mar; 6(2):169-74. PubMed ID: 15018878 [TBL] [Abstract][Full Text] [Related]
36. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. Mitchell LB; Duff HJ; Manyari DE; Wyse DG N Engl J Med; 1987 Dec; 317(27):1681-7. PubMed ID: 3320747 [TBL] [Abstract][Full Text] [Related]
37. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation. Heger JJ; Prystowsky EN; Miles WM; Zipes DP Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256 [No Abstract] [Full Text] [Related]
38. Amiodarone-induced torsades de pointes. Brown MA; Smith WM; Lubbe WF; Norris RM Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557 [TBL] [Abstract][Full Text] [Related]
39. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Cairns JA; Connolly SJ; Roberts R; Gent M Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198 [TBL] [Abstract][Full Text] [Related]
40. Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy. Gilligan DM; Missouris CG; Boyd MJ; Oakley CM Am J Cardiol; 1991 Oct; 68(9):971-3. PubMed ID: 1927963 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]